Skip to main content
. 2020 Jan 16;69(8):1404–1415. doi: 10.1136/gutjnl-2019-319188

Table 1.

Participants’ characteristics

Characteristic Gastrectomy Control P value
Number of participants 50 56
Number of participants with metabolite profiles 44 54
Gastrectomy type
 Total gastrectomy (n) 12
 Subtotal gastrectomy (n) 38
Gastrectomy reconstruction (n)
 Stomach-stomach anastomosis 1
 Billroth I 2
 Jejunal interposition 6
 Pylorus-preserving gastrectomy 8
 Roux-en-Y 29
Time since surgery (median (range) in years) 5 (1–20)
Age 61.6±10.7 64.0±11.2 0.205
Body mass index (kg/m2) 20.6±2.6 23.2±3.0 1.22×10-5
Smokers, n (%) 3 (6.0) 5 (14.3) 0.479
Gender (F/M) 16/34 23/33 0.420
Alcohol consumption (>60 g/day), n (%) 22 (44.0) 31 (55.4) 0.331
Serum glucose (mg/dL) 101.2±12.5 104.6±15.6 0.147
Total cholesterol (mg/dL) 190.4±25.7 209.0±35.8 0.0145
Medications
 Diabetes, n (%) 2 (4.2) 12 (21.8) 0.00889
 High blood pressure, n (%) 13 (26.0) 17 (30.4) 0.743
 Cholesterol, n (%) 6 (12.0) 10 (17.9) 0.502
 Gout, n (%) 0 (0) 2 (3.6) 0.497
 Gastric acid suppression, n (%) 4 (8.0) 13 (23.2) 0.0375
 Analgesic, n (%) 1 (2.0) 2 (3.6) 1.000
 Anticoagulant, n (%) 4 (8.0) 4 (7.1) 1.000
 Other, n (%) 8 (16.0) 17 (30.9) 0.108

Statistical test performed: Mann-Whitney U test for numerical data and Fisher’s exact test for categorical data; n, number of participants.

F, female; M, male.